Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Providers Embrace US FDA REMS Integration Plan But Wary Of Another iPledge ‘Failure’
Oct 28 2022
•
By
Michael McCaughan
Patients and providers stressed that back-up plans be in place when the new REMS integration software is tested. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Safety
More from Pink Sheet